Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 01, pp. 020-047
Open Access | Times Cited: 373
Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
Margaret C. Fang, Alan S. Go, Yuchiao Chang, et al.
Circulation Cardiovascular Quality and Outcomes (2010) Vol. 3, Iss. 6, pp. 624-631
Open Access | Times Cited: 189
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
Journal of Arrhythmia (2021) Vol. 37, Iss. 6, pp. 1389-1426
Open Access | Times Cited: 69
Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
Fabiana Lucà, Fabrizio Oliva, Maurizio Giuseppe Abrignani, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5955-5955
Open Access | Times Cited: 25
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study
Joris R. de Groot, Thomas W. Weiss, Peter J. Kelly, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2020) Vol. 7, Iss. FI1, pp. f30-f39
Open Access | Times Cited: 52
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
Michele Magnocavallo, Antonio Bellasi, Marco Valerio Mariani, et al.
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 83-83
Open Access | Times Cited: 36
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
Yutao Guo, Agnieszka Kotalczyk, Jacopo Francesco Imberti, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2021) Vol. 9, Iss. 2, pp. 169-176
Open Access | Times Cited: 24
Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation
Hee Tae Yu, Pil‐Sung Yang, Jinseub Hwang, et al.
Korean Circulation Journal (2019) Vol. 50, Iss. 3, pp. 267-267
Open Access | Times Cited: 15
Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis
Rokhsareh Ebrahimi, Abolfazl Barzegari, Reza Teimuri‐Mofrad, et al.
Biosensors (2022) Vol. 12, Iss. 10, pp. 773-773
Open Access | Times Cited: 9
The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry)
Seunghoon Cho, Jun Kim, Jin‐Bae Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Comparison of warfarin, rivaroxaban, and dabigatran for effectiveness and safety in atrial fibrillation patients with different CHA2DS2-VASc scores: a retrospective cohort study
Yue Zhao, Hong Ren, Shiwei Xu
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
Moutaz El Kadri, Ahmed Ghorab, Jean Joury, et al.
Avicenna Journal of Medicine (2021) Vol. 11, Iss. 02, pp. 93-102
Open Access | Times Cited: 8
Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
Giuseppe Patti, Rosa Wang, Xiaocong Li Marston, et al.
Cardiology and Therapy (2023) Vol. 12, Iss. 2, pp. 371-391
Open Access | Times Cited: 3
Patient concern regarding bleeding side effects from oral anticoagulation therapy for atrial fibrillation: an analysis from the multicentre KiCS-AF registry
Ikuko Ueda, Shun Kohsaka, Nobuhiro Ikemura, et al.
European Journal of Cardiovascular Nursing (2023) Vol. 23, Iss. 4, pp. 358-366
Open Access | Times Cited: 3
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation
Marco Vitolo, Deirdre A. Lane, Giuseppe Boriani, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2020) Vol. 7, Iss. FI1, pp. f81-f83
Open Access | Times Cited: 8
Comparison of the Treatment Persistence Among 4 Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A 5‐Year Retrospective Cohort Study
Tomohiro Aigami, Tomoyuki Ishigo, Ryo Takada, et al.
The Journal of Clinical Pharmacology (2023) Vol. 63, Iss. 6, pp. 654-663
Closed Access | Times Cited: 2
Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review
Tomasz Górnicki, Kacper Bułdyś, Dorota Zielińska, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2697-2697
Open Access | Times Cited: 2
Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
Muhyung Heo, Dong Seop Jeong, Suryeun Chung, et al.
Journal of Chest Surgery (2023) Vol. 56, Iss. 2, pp. 90-98
Open Access | Times Cited: 1
Lessons derived from post authorisation safety studies (ETNA-AF and XANTUS) on once daily direct oral anticoagulants for atrial fibrillation
Roberto Cemin, Riccardo Cappato
International Journal of Cardiology (2023) Vol. 398, pp. 131618-131618
Closed Access | Times Cited: 1
Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea
Myung‐Yong Lee, Sola Han, Oh Young Bang, et al.
Advances in Therapy (2022) Vol. 39, Iss. 7, pp. 3112-3130
Closed Access | Times Cited: 2
How to maintain an adherence to oral anticoagulant in a patient with atrial fibrillation?
С. Г. Канорский
Kardiologiia (2019) Vol. 59, Iss. 11, pp. 76-83
Open Access | Times Cited: 1
Page 1

Scroll to top